Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
THE ENVISAGED IMPACT OF THE UNIQUE IDENTIFIER ON DRUG PRODUCTS: THE PHARMACIST'S PERSPECTIVE
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: DEBONO, Mireille (University of Malta, Department of Pharmacy, Malta)
- Co-author(s): Mireille Debono: Department of Pharmacy, University of Malta, Msida, Malta
Nicolette Sammut Bartolo: Department of Pharmacy, University of Malta, Msida, Malta
Anthony Serracino Inglott: Department of Pharmacy, University of Malta, Msida, Malta
BackgroundThe Falsified Medicines Directive introduced by the European Union (EU) includes a unique identifier which decommissions every medicinal product at the point of dispensing in every EU member state.
MethodsA validated questionnaire was disseminated to assess participants' views on the envisaged impact of the unique identifier. The.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019